Protalix BioTherapeutics, Inc.
PLX- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001006281
No open-market purchases or sales by Protalix BioTherapeutics, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $33.7M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Protalix BioTherapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −3 vs. Q3 2021
- Shares held
- 3.02M
- −1.39M (−31.5%) vs. Q3 2021
- Total value
- $2.52M
- −$3.39M (−57.4%) vs. Q3 2021
- New holders
- 8
- 7 more added
- Sold out
- 11
- 10 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 101 | $33.7M |
| Q1 2026 | 100 | $36.6M |
| Q4 2025 | 83 | $26.8M |
| Q3 2025 | 77 | $31.0M |
| Q2 2025 | 63 | $17.6M |
| Q1 2025 | 63 | $21.0M |
| Q4 2024 | 46 | $8.40M |
| Q3 2024 | 45 | $3.53M |
| Q2 2024 | 66 | $6.60M |
| Q1 2024 | 64 | $12.4M |
| Q4 2023 | 66 | $18.1M |
| Q3 2023 | 61 | $15.2M |
| Q2 2023 | 66 | $17.9M |
| Q1 2023 | 34 | $6.15M |
| Q4 2022 | 26 | $4.87M |
| Q3 2022 | 27 | $3.70M |
| Q2 2022 | 30 | $1.30M |
| Q1 2022 | 32 | $1.29M |
| Q4 2021 | 31 | $2.52M |
| Q3 2021 | 35 | $5.91M |
| Q2 2021 | 33 | $8.71M |
| Q1 2021 | 38 | $39.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Protalix BioTherapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 1,292,963 | $1.07M | 0.00% | −992,112−43.4% | Reduced |
| Group One Trading, L.P. | 630,546 | $524.0K | 0.01% | +407,993+183.3% | Added |
| Phoenix Holdings Ltd. | 244,113 | $203.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 163,900 | $136.0K | 0.00% | −87,271−34.7% | Reduced |
| Spire Wealth Management | 125,800 | $113.0K | 0.00% | +107,800+598.9% | Added |
| BlackRock Inc. | 114,398 | $95.0K | 0.00% | −5,157−4.3% | Reduced |
| Two Sigma Advisers, LP | 99,900 | $83.0K | 0.00% | +85,700+603.5% | Added |
| Jane Street Group, LLC | 85,658 | $71.0K | 0.00% | +44,709+109.2% | Added |
| Susquehanna Fundamental Investments, LLC | 42,900 | $36.0K | 0.00% | −16,600−27.9% | Reduced |
| Commonwealth Equity Services, LLC | 40,290 | $33.0K | 0.00% | +40,290 | New |
| Citadel Advisors LLC | 29,015 | $24.0K | 0.00% | +4,070+16.3% | Added |
| Gsa Capital Partners LLP | 24,527 | $20.0K | 0.00% | −230,344−90.4% | Reduced |
| IHT Wealth Management, LLC | 24,000 | $20.0K | 0.00% | −9,200−27.7% | Reduced |
| Virtu Financial LLC | 18,371 | $15.0K | 0.00% | +18,371 | New |
| Bank of America Corp | 17,387 | $14.0K | 0.00% | +8,497+95.6% | Added |
| Finivi Inc. | 14,544 | $12.1K | 0.01% | +14,544 | New |
| Davenport & Co LLC | 12,000 | $10.0K | 0.00% | −24,000−66.7% | Reduced |
| Cutler Group LP | 10,067 | $8.00K | 0.00% | −1,200−10.7% | Reduced |
| TD Waterhouse Canada Inc. | 6,000 | $5.76K | 0.00% | +6,000 | New |
| Federated Hermes, Inc. | 5,761 | $5.00K | 0.00% | 00.0% | Unchanged |
| Psagot Value Holdings Ltd. / (Israel) | 6,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 6,000 | $5.00K | 0.00% | +6,000 | New |
| Migdal Insurance & Financial Holdings Ltd. | 2,432 | $2.00K | 0.00% | −1,568−39.2% | Reduced |
| Captrust Financial Advisors | 800 | $1.00K | 0.00% | 00.0% | Unchanged |
| Ten Capital Wealth Advisors, LLC | 650 | $1.00K | 0.00% | +98+17.8% | Added |
| Federation des caisses Desjardins du Quebec | 1,100 | $915 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 120 | $0 | 0.00% | −2,194−94.8% | Reduced |
| Royal Bank of Canada | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 72 | $0 | 0.00% | +72 | New |
| Rinkey Investments | 100 | $0 | 0.00% | +100 | New |
| Snowden Capital Advisors LLC | 500 | $0 | 0.00% | +500 | New |
| Meitav Dash Investments Ltd | 0 | $0 | 0.00% | −244,332−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −220,089−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −69,049−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −81,000−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −58,890−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −31,974−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −28,168−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −20,514−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −5,847−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Psagot Investment House Ltd. | – | – | – | – | Not filed |